{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:13:58Z","timestamp":1760242438393,"version":"3.40.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/jid.2008.430","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T11:08:55Z","timestamp":1235646535000},"page":"1703-1709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bcl-xL Gene Expression Correlated with Lower Apoptotic Cell Numbers and Shorter Progression-Free Survival in PCFCL"],"prefix":"10.1016","volume":"129","author":[{"given":"Razieh","family":"Soltani-Arabshahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Rivet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Pisonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Bachelez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Ameisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Janin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2008.430_bb0010","first-page":"6101","article-title":"An informatics approach identifying markers of chemosensitivity in human cancer cell lines","volume":"60","author":"Amundson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2008.430_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2006.06.017","article-title":"Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas","volume":"38","author":"Bai","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1038\/jid.2008.430_bb0020","first-page":"432","article-title":"Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma","volume":"137","author":"Bergman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2008.430_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","article-title":"bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death","volume":"74","author":"Boise","year":"1993","journal-title":"Cell"},{"key":"10.1038\/jid.2008.430_bb0030","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/MCB.20.5.1886-1896.2000","article-title":"Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway","volume":"20","author":"Breitschopf","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1038\/jid.2008.430_bb0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/jm061152t","article-title":"Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL","volume":"50","author":"Bruncko","year":"2007","journal-title":"J Med Chem"},{"key":"10.1038\/jid.2008.430_bb0040","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0045","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2008.430_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2008.430_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2008.430_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V81.2.293.293","article-title":"Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues","volume":"81","author":"Chleq-Deschamps","year":"1993","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(86)90362-4","article-title":"Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation","volume":"47","author":"Cleary","year":"1986","journal-title":"Cell"},{"key":"10.1038\/jid.2008.430_bb0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2141.2001.02603.x","article-title":"In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID\/NOD-Hu model","volume":"112","author":"Fennell","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1038\/jid.2008.430_bb0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V91.1.244","article-title":"Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival","volume":"91","author":"Ghia","year":"1998","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2559.2006.02501.x","article-title":"BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma","volume":"49","author":"Goodlad","year":"2006","journal-title":"Histopathology"},{"key":"10.1038\/jid.2008.430_bb0085","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","article-title":"Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas","volume":"103","author":"Grange","year":"2004","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0090","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1158\/1078-0432.CCR-05-0637","article-title":"Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma","volume":"11","author":"Gulmann","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2008.430_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.430_bb0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.0022-202X.2003.12635.x","article-title":"Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas","volume":"122","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.430_bb0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/348334a0","article-title":"Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death","volume":"348","author":"Hockenbery","year":"1990","journal-title":"Nature"},{"key":"10.1038\/jid.2008.430_bb0110","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2008.430_bb0120","first-page":"1183","article-title":"Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis","volume":"2","author":"Jazirehi","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/jid.2008.430_bb0125","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1182\/blood.V80.8.2044.2044","article-title":"Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization","volume":"80","author":"Kondo","year":"1992","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1440-1827.2007.02115.x","article-title":"Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis","volume":"57","author":"Kondo","year":"2007","journal-title":"Pathol Int"},{"key":"10.1038\/jid.2008.430_bb0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1309\/2TJU-DNLQ-5JBA-AB4T","article-title":"The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade","volume":"118","author":"Lawnicki","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2008.430_bb0140","first-page":"2271","article-title":"Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia","volume":"6","author":"Limpens","year":"1991","journal-title":"Oncogene"},{"key":"10.1038\/jid.2008.430_bb0145","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0150","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1182\/blood-2003-10-3399","article-title":"Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies","volume":"103","author":"Linden","year":"2004","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"key":"10.1038\/jid.2008.430_bb0160","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2005.05954.x","article-title":"Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma","volume":"132","author":"Michels","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1038\/jid.2008.430_bb0165","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V86.5.1903.bloodjournal8651903","article-title":"Expression of bcl-xL can confer a multidrug resistance phenotype","volume":"86","author":"Minn","year":"1995","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0170","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2002.20.3.647","article-title":"Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features","volume":"20","author":"Mirza","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2008.430_bb0175","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7878471","article-title":"Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice","volume":"267","author":"Motoyama","year":"1995","journal-title":"Science"},{"key":"10.1038\/jid.2008.430_bb0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2567.2005.02117.x","article-title":"Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia","volume":"114","author":"Packham","year":"2005","journal-title":"Immunology"},{"key":"10.1038\/jid.2008.430_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beha.2004.06.002","article-title":"The clinical course of follicular lymphoma","volume":"18","author":"Rohatiner","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1038\/jid.2008.430_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1689","article-title":"Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation","volume":"205","author":"Schraders","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/jid.2008.430_bb0195","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1158\/0008-5472.CAN-06-0367","article-title":"A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo","volume":"66","author":"Shoemaker","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2008.430_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1269\/jrr.46.241","article-title":"Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells","volume":"46","author":"Skvortsova","year":"2005","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1038\/jid.2008.430_bb0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","article-title":"Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas","volume":"30","author":"Streubel","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/jid.2008.430_bb0210","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1038\/jid.2008.430_bb0215","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1038\/jid.2008.430_bb0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.cco.0000239879.31463.42","article-title":"Primary cutaneous B-cell lymphoma: classification and treatment","volume":"18","author":"Willemze","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/jid.2008.430_bb0225","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0230","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1046\/j.1365-2141.1996.423958.x","article-title":"Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas","volume":"92","author":"Xerri","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1038\/jid.2008.430_bb0235","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00000478-200005000-00008","article-title":"Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/jid.2008.430_bb0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V88.2.386.bloodjournal882386","article-title":"Molecular thanatopsis: a discourse on the BCL2 family and cell death","volume":"88","author":"Yang","year":"1996","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/labinvest.3700051","article-title":"Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray","volume":"84","author":"Zha","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/jid.2008.430_bb0250","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2003-06-1901","article-title":"Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma","volume":"103","author":"Zhao","year":"2004","journal-title":"Blood"},{"key":"10.1038\/jid.2008.430_bb0255","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15343967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15343967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:34:26Z","timestamp":1743939266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15343967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0022202X15343967"],"URL":"https:\/\/doi.org\/10.1038\/jid.2008.430","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bcl-xL Gene Expression Correlated with Lower Apoptotic Cell Numbers and Shorter Progression-Free Survival in PCFCL","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2008.430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}